The parent molecule and the fragment
Thymosin β-4 is a naturally occurring 43-amino-acid protein and one of the most abundant actin-sequestering proteins in mammalian cells. TB-500 corresponds to its active region rather than the full protein. Researchers use the fragment as a focused tool: it isolates the actin-related activity attributed to the parent molecule without the rest of the sequence, which makes cause and effect easier to attribute in an assay.
The LKKTETQ motif and G-actin binding
The mechanistic core is a seven-residue sequence, LKKTETQ, which binds monomeric globular actin (G-actin). Actin exists in equilibrium between this free monomer pool and polymerized filaments (F-actin). By binding G-actin, the motif acts on that equilibrium — sequestering monomers and thereby influencing the rate and location of actin polymerization within the cell.
This matters because the actin cytoskeleton is not static scaffolding. It is continuously assembled and disassembled to change cell shape, generate protrusive force, and set direction of travel. A molecule that modulates the available monomer pool is, functionally, a modulator of cytoskeletal remodeling.
From cytoskeletal dynamics to directed cell migration
The downstream consequence studied most often is directed cell migration. Cells move by polymerizing actin at the leading edge while disassembling it at the rear; controlling monomer availability influences how readily that cycle proceeds. In injury and wound-model systems, research examines whether cells migrate toward the affected site more readily in the presence of the peptide. These are in-vitro and animal-model observations, not clinical outcomes.
Angiogenesis and endothelial migration
A related line of published investigation looks at angiogenesis — new vessel formation — and endothelial cell migration specifically. Because endothelial sprouting is itself a migration-dependent process, the actin mechanism above provides a plausible link. Studies in this area remain confined to cell culture and animal models, and the literature treats the connection as a research question rather than a settled pathway.
What the mechanism does not establish
Actin sequestration is a well-characterized biochemical property; the translation of that property into any specific biological outcome is where the evidence thins. Research models are constructed environments, and results in murine tissue or cultured cells do not establish effects in any other context. TB-500 is not approved for human or veterinary use, and no dosing or therapeutic guidance exists or is provided here.
Reference data
| Compound | TB-500 · Thymosin β-4 fragment |
| Molecular weight | 4,963.4 g/mol |
| Sequence / form | Contains the LKKTETQ actin-binding motif |
| Research class | Regenerative |
| Verification | Independent five-point panel (MZ Biolabs, Arizona) — lot-specific COA |
Where it appears in research
- Actin-sequestration and cytoskeletal dynamics assays
- Cell-migration and chemotaxis models
- Angiogenesis and endothelial research
- Cardiac and dermal tissue-repair models
Ethos Bio supplies TB-500 strictly as a research reagent. Every lot is independently verified by MZ Biolabs, a third-party analytical laboratory in Arizona, on a five-point panel — RP-HPLC purity, HPLC-MS identity, endotoxin (LAL), heavy metals, and sterility — with a lot-specific Certificate of Analysis shipped alongside the vial.
TB-500 reference materials
Read the full monograph for sequence, specifications, and research context, or review the lot-specific certificate of analysis.
Frequently asked questions
What is the mechanism of action of TB-500?
In research models TB-500 binds monomeric G-actin through its LKKTETQ motif, sequestering actin monomers and influencing actin polymerization and cytoskeletal remodeling. Downstream research examines directed cell migration and angiogenesis. All findings are in-vitro or animal-model based.
What is the LKKTETQ motif?
LKKTETQ is the seven-residue actin-binding sequence within Thymosin β-4 that TB-500 contains. It is the structural feature responsible for the peptide’s G-actin binding and the basis of its studied cytoskeletal activity.
How is TB-500 different from Thymosin β-4?
Thymosin β-4 is the full naturally occurring 43-amino-acid protein; TB-500 represents its active actin-binding fragment. Researchers use the fragment as a focused tool for studying the actin-related activity attributed to the parent molecule.
Is TB-500 approved for human use?
No. TB-500 is sold strictly for laboratory research use only. It is not a drug or supplement and is not approved for human or veterinary use or consumption.